A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy
Matthew T. Wolf, Sudipto Ganguly, Tony L. Wang, Christopher W. Anderson, Kaitlyn Sadtler, Radhika Narain, Christopher Cherry, Alexis J. Parrillo, Benjamin V. Park, Guannan Wang, Fan Pan, Saraswati Sukumar, Drew M. Pardoll, Jennifer H. Elisseeff
Dive into the research topics of 'A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy'. Together they form a unique fingerprint.